WuXi XDC Cayman Company Description

WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

It engages in the discovery, research, development, and manufacture of the drug substances and drug products of antibody drug conjugates, bioconjugates, monoclonal antibody intermediates, and payload-linkers associated with bioconjugates.

It also provides international sales contracting services. The company was founded in 2013 and is headquartered in Wuxi, China.

WuXi XDC Cayman Inc. operates as a subsidiary of WuXi Biologics (Cayman) Inc.

WuXi XDC Cayman Inc.

Country	Cayman Islands
Founded	2013
Industry	Diagnostics & Research
Sector	Healthcare
Employees	1,178
CEO	Jincai Li

Contact Details

Address: No. 11 Xinhui Ring Road Wuxi China
Website	wuxixdc.com

Stock Details

Ticker Symbol	2268
Exchange	Hong Kong Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	KYG9808A1058
SIC Code	2834

Key Executives

Name	Position
Dr. Jincai Li Ph.D.	Chief Executive Officer and Executive Director
Xiaojie Xi	Company Secretary, Chief Financial Officer and Executive Director
Jingwei Zhang	Chief Operating Officer and Executive Director
Dr. Meiying Zhu	Chief Technology Officer
Dr. Jianjun Luo	Vice President